Literature DB >> 20510824

The epidemiology and socioeconomic impact of chronic pancreatitis.

James Jupp1, David Fine, Colin D Johnson.   

Abstract

Epidemiological studies have been published worldwide in recent decades describing the incidence, mortality, aetiology and trends of chronic pancreatitis. Accumulated evidence suggests that chronic pancreatitis is increasing in incidence and hospital admission rates are rising accordingly. Alcoholic chronic pancreatitis was previously more common in the developed world than elsewhere, but is now increasing worldwide due to growing per capita alcohol consumption in each nation. Supporting alcohol and smoking cessation in individual patients is essential to slow disease progression and improve overall health, as most patients will die of cirrhosis, cardiovascular disease or smoking related cancers rather than chronic pancreatitis. The socioeconomic impact of chronic pancreatitis is difficult to quantify as little data exists, however given the rising incidence the costs to health care and society are likely to increase. This chapter will describe the epidemiology and aetiology of chronic pancreatitis worldwide and discusses the factors that influence its socioeconomic impact. 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20510824     DOI: 10.1016/j.bpg.2010.03.005

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  23 in total

1.  The pain of chronic pancreatitis: a persistent clinical challenge.

Authors:  Michael R Goulden
Journal:  Br J Pain       Date:  2013-02

Review 2.  The nutritional management of type 3c (pancreatogenic) diabetes in chronic pancreatitis.

Authors:  S N Duggan; N Ewald; L Kelleher; O Griffin; J Gibney; K C Conlon
Journal:  Eur J Clin Nutr       Date:  2016-07-13       Impact factor: 4.016

Review 3.  Unraveling the mystery of pain in chronic pancreatitis.

Authors:  Pankaj Jay Pasricha
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-01-24       Impact factor: 46.802

4.  Cost-effectiveness of total pancreatectomy and islet cell autotransplantation for the treatment of minimal change chronic pancreatitis.

Authors:  Gregory C Wilson; Syed A Ahmad; Daniel P Schauer; Mark H Eckman; Daniel E Abbott
Journal:  J Gastrointest Surg       Date:  2014-08-06       Impact factor: 3.452

Review 5.  Animal models of gastrointestinal and liver diseases. Animal models of acute and chronic pancreatitis.

Authors:  Xianbao Zhan; Fan Wang; Yan Bi; Baoan Ji
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-07-14       Impact factor: 4.052

Review 6.  Chronic pancreatitis: A diagnostic dilemma.

Authors:  Sinead N Duggan; Hazel M Ní Chonchubhair; Oladapo Lawal; Donal B O'Connor; Kevin C Conlon
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

Review 7.  Pancreatic pain.

Authors:  Hana Nechutova; Petr Dite; Marketa Hermanova; Ivo Novotny; Arnost Martinek; Pavel Klvana; Bohumil Kianicka; Miroslav Soucek
Journal:  Wien Med Wochenschr       Date:  2014-03-12

8.  Gremlin is a key pro-fibrogenic factor in chronic pancreatitis.

Authors:  Dustin Staloch; Xuxia Gao; Ka Liu; Meihua Xu; Xueping Feng; Judith F Aronson; Miriam Falzon; George H Greeley; Cristiana Rastellini; Celia Chao; Mark R Hellmich; Yanna Cao; Tien C Ko
Journal:  J Mol Med (Berl)       Date:  2015-07-05       Impact factor: 4.599

9.  Gastrointestinal symptoms before and after total pancreatectomy with islet autotransplantation: the role of pancreatic enzyme dosing and adherence.

Authors:  Jill Crosby; Melena D Bellin; David M Radosevich; Srinath Chinnakotla; Ty B Dunn; Timothy L Pruett; Martin L Freeman; Greg J Beilman; Sarah J Schwarzenberg
Journal:  Pancreas       Date:  2015-04       Impact factor: 3.327

10.  Incidence and mortality of acute and chronic pancreatitis in the Netherlands: a nationwide record-linked cohort study for the years 1995-2005.

Authors:  B W Marcel Spanier; Marco J Bruno; Marcel G W Dijkgraaf
Journal:  World J Gastroenterol       Date:  2013-05-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.